These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28479897)

  • 21. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sociodemographic and clinical factors associated with relapse in schizophrenia.
    Chabungbam G; Avasthi A; Sharan P
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):587-93. PubMed ID: 18081617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-morbid anxiety disorders in patients with schizophrenia in a tertiary institution in South East Nigeria: prevalence and correlates.
    Aguocha C; Aguocha K; Uwakwe R; Onyeama G
    Afr Health Sci; 2015 Mar; 15(1):137-45. PubMed ID: 25834542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationships between positive or negative early subjective response to antipsychotics and demographic and clinical variables in the group of patients with schizophrenia].
    Murawiec S
    Psychiatr Pol; 2005; 39(6):1185-98. PubMed ID: 16526184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria.
    Adewuya AO; Ola BA; Mosaku SK; Fatoye FO; Eegunranti AB
    Acta Psychiatr Scand; 2006 Mar; 113(3):207-11. PubMed ID: 16466404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of antipsychotic treatment type and regimen on the functionality of patients with schizophrenia.
    Acosta FJ; Chinea E; Hernández JL; Rodríguez F; García-Bello M; Medina G; Nieves W
    Nord J Psychiatry; 2014 Apr; 68(3):180-8. PubMed ID: 23672274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-stigma, quality of life and schizophrenia: An outpatient clinic survey in Nigeria.
    Mosanya TJ; Adelufosi AO; Adebowale OT; Ogunwale A; Adebayo OK
    Int J Soc Psychiatry; 2014 Jun; 60(4):377-86. PubMed ID: 23828766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries.
    Barbui C; Nosè M; Mazzi MA; Bindman J; Leese M; Schene A; Becker T; Angermeyer MC; Koeter M; Gray R; Tansella M
    Int Clin Psychopharmacol; 2006 Mar; 21(2):73-9. PubMed ID: 16421457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare.
    Kadra G; Stewart R; Shetty H; Downs J; MacCabe JH; Taylor D; Hayes RD
    Schizophr Res; 2016 Jul; 174(1-3):106-112. PubMed ID: 27091655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA; Levine SZ; Tanaka S; Goldberg Y; Samara M; Davis JM; Cipriani A; Leucht S
    JAMA Psychiatry; 2015 Jan; 72(1):14-21. PubMed ID: 25372935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
    J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
    Kerwin R; Millet B; Herman E; Banki CM; Lublin H; Pans M; Hanssens L; L'Italien G; McQuade RD; Beuzen JN
    Eur Psychiatry; 2007 Oct; 22(7):433-43. PubMed ID: 17555947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison Of Effectiveness Of Antipsychotics In Schizophrenia: Second-Generation Versus The Irstgeneration.
    Zubair UB; Ali SA; Taj R; Batool SM
    J Ayub Med Coll Abbottabad; 2020; 32(1):24-27. PubMed ID: 32468749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia.
    Yin Y; Li S; Tong J; Huang J; Tian B; Chen S; Cui Y; Tan S; Wang Z; Yang F; Tong Y; Hong LE; Tan Y
    Schizophr Res; 2023 Jul; 257():58-63. PubMed ID: 37290277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The subjective quality of life of patients with schizophrenia: influence of psychopathology and patients' expectations. A comparative study].
    Salomé F; Petitjean F; Germain C; Demant JC
    Encephale; 2004; 30(1):60-8. PubMed ID: 15029078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials.
    Stauffer V; Case M; Kollack-Walker S; Ascher-Svanum H; Ball T; Kapur S; Kinon BJ
    Schizophr Res; 2011 Aug; 130(1-3):11-9. PubMed ID: 21489754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.